NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments

National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis details clarified expert consensus to help guide providers on latest data and information, available at NCCN.org/covid-19.

Dentists and Dental Hygienists on Early Front Lines of COVID-19 Report Symptoms of Anxiety, Depression

Dental health care workers reported higher rates of anxiety and depression during peaks of COVID-19 transmission among the public, according to a study jointly published in the August issues of The Journal of the American Dental Association and the Journal of Dental Hygiene. it is the first known U.S. study to evaluate the mental health of front-line dentists and dental hygienists during the pandemic.

Most COVID-19 long-haulers continue to experience neurologic symptoms, fatigue, and compromised quality of life 15 months after initial infection

A new study published in Annals of Clinical and Translational Neurology looked at the evolution of neurologic symptoms in non-hospitalized COVID-19 long-haulers at the Northwestern Medicine Neuro COVID-19 Clinic and discovered most long-haulers continue to experience symptoms such as brain fog, numbness/tingling, headache, dizziness, blurred vision, tinnitus and fatigue on average of 15 months after disease onset.

New study finds persistent viral shedding of COVID-19 is associated with delirium and six-month mortality in hospitalized COVID-19 patients

The Northwestern Medicine Neuro COVID-19 research team discovered patients who continued to test positive more than 14 days after their initial positive test were more likely to experience delirium, longer hospital stays, were less likely to be discharged home, and had a greater six-month mortality than those without persistent viral shedding of COVID-19.

Used Face Masks – Infectious Waste that Requires Proper Disposal

Chula Engineering professor proposes ways to manage used masks and ATK test kits by choosing reusable masks, separating infectious waste, and preparing it properly before discarding it to be destroyed in a non-polluting disposal system to reduce overflowing waste problem.

Seniors Should Stay Fit, Body & Mind – Chula Suggests Ways to Exercise Safely at Home to Keep COVID-19 Away

Chula physical therapy specialist invites seniors to exercise to boost their immunity against COVID-19 and stay fit even during home quarantine with easy ways to exercise at home during the lockdown.

“Automated Vaccine Filling Machine”, An Innovation from Chulalongkorn University, Helps Boost the Number of Vaccinations by 20 Percent, and Reduce the Workload of Medical Personnel

The Faculty of Engineering, Chulalongkorn University has developed an automated vaccine filling machine that can fill AstraZeneca vaccine into syringes with precision, speed, and safety, helping to increase the number of vaccinated people by 20 percent. The prototype is now operating at Chula Vaccination Center and more machines are planned to be built to support frontline medical personnel in many vaccination centers soon.

Cancer Guidelines Organization Supports Mandatory COVID-19 Vaccination for Health Workers

National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee calls for healthcare workforce vaccine requirements to assure healthcare community is doing all it can to prevent exposure to COVID-19.

Treating newly infected COVID-19 patients with plasma from COVID survivors demonstrates no significant benefit, study finds

A NIH study co-led and designed by Michigan Medicine researchers found that using convalescent plasma to treat newly infected #COVID-19 patients demonstrated no significant benefit. The trial was stopped in February 2021 due to lack of efficacy based on planned interim analysis

Treating newly infected COVID-19 patients with plasma from COVID survivors demonstrates no significant benefit, study finds

A NIH study co-led and designed by Michigan Medicine researchers found that using convalescent plasma to treat newly infected #COVID-19 patients demonstrated no significant benefit. The trial was stopped in February 2021 due to lack of efficacy based on planned interim analysis

American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Say Preoperative Testing for COVID-19 is Essential, Regardless of Vaccination

All patients undergoing non-emergency surgeries or procedures should continue to have preoperative polymerase chain reaction (PCR) testing for SARS-CoV-2, irrespective of vaccination status, according to an updated guidance from the American Society of Anesthesiologists and Anesthesia Patient Safety Foundation.

Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.

Appropriate Technologies: The COVID-19-Era Heroes Yet to Come to “Center Stage”

The COVID-19 outbreaks in Thailand have seen an ever-increasing number of infections as new clusters are emerging. The faculty members of Sasin School of Management — Prof. Dr. Kua Wongboonsin, Asst. Prof. Dr. Piyachart Phiromswad, Assoc. Prof. Dr. Pattanaporn Chatjuthamard, Asst. Prof. Dr. Pattarake Sarajoti, and Asst. Prof. Dr. Sabin Srivannaboon, with financial support from the National Research Council of Thailand (NRCT), jointly present ways to reduce the spread of COVID-19 sustainably in a study to identify technologies that can instantly and appropriately help professionals who find social distancing difficult.

2 in 1 Face Mask Against Dust and Virus – Chula Health Innovation in the New Normal

Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.

Study of Cancer Patients and COVID-19 Highlights Health Disparities

Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and Syapse®, show an elevated risk for severe COVID-19 effects or death among patients with cancer, with the highest risk being among low-income and Black patients.

COVID-19 SCAN: An Innovative, Proactive, Fast, Accurate, and Affordable Screening Kit by Chula Doctors

As the COVID-19 outbreaks continue to skyrocket with new clusters in numerous dark red areas in many provinces across the country, a research team led by Assoc. Prof. Dr. Sanchai Payungporn, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, has, therefore, accelerated the development of the innovative COVID-19 screening kits – “COVID-19 SCAN” that are convenient, fast, inexpensive, with efficiency, accuracy close to the Real-time PCR standards mandated by the Ministry of Public Health.

NCCN Policy Summit Explores How COVID-19 Pandemic Can Lead to Improvements in Cancer Care

NCCN Policy Summit examines the impact of the past year on oncology policy in the U.S., such as resuming recommended screening and clinical trials, applying health innovations from the COVID-19 pandemic to cancer treatment, and addressing systemic inequalities that lead to disparities in outcomes.

What to Expect From COVID-19

Throughout the country, states are opening up and lifting COVID-19 restrictions that have been in place for more than a year at a time when only about a third of Americans have been fully vaccinated and less than a half have received at least one dose.

Perry N. Halkitis, dean of the Rutgers School of Public Health, discusses how to interpret new guidelines, what to expect in the coming months, and if this is an indication that life is returning to normal.

Nearly 3% of Americans take immune-weakening drugs that may limit COVID vaccine response

A study of more than 3 million insured U.S. adult patients under 65 found that nearly 3% take immunosuppressive drugs that may elevate risk for severe COVID-19 symptoms and hospitalization if they became infected. There is growing evidence that immunosuppressive drugs may also reduce the COVID vaccine’s efficacy.

Chula to Accelerate Research on “Rutin” — An Herbal Extract Against COVID-19

Chula researchers have found that “rutin” extract from orange peel can kill the COVID-19 virus. They are developing it into drugs while pointing out that drug research is still necessary along with vaccine research and suggesting that Thai people should adjust their views on herbs to create added value.

Baylor Scott & White Sports Therapy & Research Publishes New Data on Impacts of Mask Wearing on Sports Performance

Baylor Scott & White Sports Therapy & Research at The Star in Frisco has published new findings from a study designed to determine the effects of wearing a cloth mask on sports performance. The data from this randomized controlled trial, conducted through Baylor Scott & White Research Institute, has been published in the British Journal of Sports Medicine and shows that participants who wore cloth masks during exercise experienced a reduction in performance as intensity levels increased.

Chula Pharmaceutical Science Developed Herbal Nasal and Throat Spray to Prevent COVID-19 Infection

Chula Pharmaceutical Science, in collaboration with leading a Austrian institute, came up with a special intensive longan extract formula (P80) for throat and nasal spray that can reduce the amount of viruses that attach to the mucous membranes that may enter the body. Helps safely prevent all kinds of viral infections including the COVID-19 virus, with no side effects.

Equitably Allocating COVID-19 Vaccine

Equitable implementation of COVID‐19 vaccine delivery is a national and global priority, with a strong focus on reducing existing disparities and not creating new disparities. But while a framework has been recognized for equitable allocation of COVID‐19 vaccine that acknowledges the rights and interests of sexual and gender minorities (SGM), it fails to identify strategies or data to achieve that goal.

Study suggests COVID-19 pandemic may have led to increased legal cannabis use in at-risk communities

The aim of the current study is to examine whether communities reporting an increased risk for developing mental health issues showed differential patterns of legal cannabis use as the pandemic began. A secondary goal is to examine the feasibility of using anonymized location data to uncover community consumption patterns of potential concern.

April 2021 Issue of AJPH highlights COVID-19 as it relates to unemployment and excess deaths in Florida, Medicaid expansion, and misinformation spread by crowdfunding campaigns

April 2021 highlights from AJPH Issue includes COVID-19-related articles around deaths linked to unemployment, higher than reported death toll in Florida and crowdfunding campaigns spreading misinformation

Promoting and Protecting Human Milk and Breastfeeding During COVID-19

With stressors mounting daily on the health care system due to the COVID-19 pandemic, a de-prioritization of the childbearing family has been noted. Their care has changed, resulting in mothers forced to go through labor and birth without their partners, parents barred from NICU visitation, and discharge of mothers and newborns early without enough expert lactation care. There is great concern that these changes in childbearing families’ care may become permanent – to the detriment of the health of both mother and child.

Vaccine Prioritization Dashboard Launches @JohnsHopkins for People with Disabilities

A new Johns Hopkins data tool helps people with disabilities determine when they qualify for the COVID-19 vaccine and compares how different states prioritize the disability community in the vaccine rollout.

Created by researchers, students and advocates who themselves are disabled and have personally experienced how inequitable and inaccessible the pandemic response has been, the COVID-19 Vaccine Prioritization Dashboard launched to not only help the disability community get vaccinated, but also to arm policymakers with data to improve the system.

Negligible Detection of SARS-CoV2 found in Environmental Surface Testing of Hematology/Oncology Inpatient and Outpatient Settings

Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study, published in Cancer, revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.